Status: current, Defined. Date: 31-Aug 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 253221000036112 | Revasc (desirudin 15 mg) powder for injection [2 x 15 mg vials] (&) (inert substance) diluent [2 x 1 mL ampoules], 1 pack (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 253231000036114 | Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | Is a | trade product pack | true | Inferred relationship | Some | ||
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | Is a | desirudin 15 mg injection [2 vials] (&) inert substance diluent [2 x 1 mL ampoules], 1 pack | true | Inferred relationship | Some | ||
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | has TPUU | Revasc (desirudin 15 mg) powder for injection, 15 mg vial | true | Inferred relationship | Some | 1 | |
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | has TPUU | Revasc (inert substance) diluent, 1 mL ampoule | true | Inferred relationship | Some | 2 | |
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | has TP | Revasc | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | Is a | True | Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR